Free Trial

Leerink Partners Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leerink Partners. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leerink Partners.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
$1.03
+4.2%
12/12/2024Reiterated byLeerink Partners-Outperform -> Market Perform$11.00 -> $2.00N/AView details for Leerink Partners rating of LAVA Therapeutics (NASDAQ:LVTX) on 12/12/2024
uniQure stock logo
QURE
uniQure
$16.98
+9.8%
12/11/2024Target Raised byLeerink Partners-Outperform -> Outperform$26.00 -> $44.00N/AView details for Leerink Partners rating of uniQure (NASDAQ:QURE) on 12/11/2024
Patterson Companies stock logo
PDCO
Patterson Companies
$30.86
-0.2%
12/11/2024Reiterated byLeerink Partners-Outperform -> Market Perform$29.00 -> $31.35N/AView details for Leerink Partners rating of Patterson Companies (NASDAQ:PDCO) on 12/11/2024
Q32 Bio stock logo
QTTB
Q32 Bio
$3.59
+7.5%
12/11/2024Reiterated byLeerink Partners-Outperform -> Market Perform$68.00 -> $9.00N/AView details for Leerink Partners rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024
ANI Pharmaceuticals stock logo
ANIP
ANI Pharmaceuticals
$53.35
-1.7%
12/11/2024Initiated byLeerink Partners-Outperform$80.00N/AView details for Leerink Partners rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 12/11/2024
Myriad Genetics stock logo
MYGN
Myriad Genetics
$13.36
+1.4%
12/9/2024Downgraded byLeerink Partners-Outperform -> Market Perform$30.00 -> $21.00N/AView details for Leerink Partners rating of Myriad Genetics (NASDAQ:MYGN) on 12/9/2024
OnKure Therapeutics stock logo
OKUR
OnKure Therapeutics
$8.38
+4.1%
12/5/2024Initiated byLeerink Partners-Outperform$33.00N/AView details for Leerink Partners rating of OnKure Therapeutics (NASDAQ:OKUR) on 12/5/2024
Relmada Therapeutics stock logo
RLMD
Relmada Therapeutics
$0.36
+2.9%
12/4/2024Reiterated byLeerink Partners-Outperform -> Market Perform$10.00 -> $1.00N/AView details for Leerink Partners rating of Relmada Therapeutics (NASDAQ:RLMD) on 12/4/2024
Relay Therapeutics stock logo
RLAY
Relay Therapeutics
$4.16
-2.3%
12/4/2024Target Lowered byLeerink Partners-Outperform -> Outperform$19.00 -> $18.00N/AView details for Leerink Partners rating of Relay Therapeutics (NASDAQ:RLAY) on 12/4/2024
Janux Therapeutics stock logo
JANX
Janux Therapeutics
$56.83
+0.1%
12/3/2024Target Raised byLeerink Partners-Outperform -> Outperform$79.00 -> $91.00N/AView details for Leerink Partners rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024
Climb Bio stock logo
CLYM
Climb Bio
$1.95
12/2/2024Initiated byLeerink Partners-Outperform$10.00N/AView details for Leerink Partners rating of Climb Bio (NASDAQ:CLYM) on 12/2/2024
Zoetis stock logo
ZTS
Zoetis
$164.84
+0.8%
12/2/2024Initiated byLeerink Partners-Outperform$215.00N/AView details for Leerink Partners rating of Zoetis (NYSE:ZTS) on 12/2/2024
IDEXX Laboratories stock logo
IDXX
IDEXX Laboratories
$412.26
+0.8%
12/2/2024Initiated byLeerink Partners-Outperform$500.00N/AView details for Leerink Partners rating of IDEXX Laboratories (NASDAQ:IDXX) on 12/2/2024
Elanco Animal Health stock logo
ELAN
Elanco Animal Health
$11.63
-1.6%
12/2/2024Initiated byLeerink Partners-Market Perform$14.00N/AView details for Leerink Partners rating of Elanco Animal Health (NYSE:ELAN) on 12/2/2024
Amgen stock logo
AMGN
Amgen
$263.38
+0.8%
11/27/2024Target Lowered byLeerink Partners-$349.00 -> $302.00N/AView details for Leerink Partners rating of Amgen (NASDAQ:AMGN) on 11/27/2024
Janux Therapeutics stock logo
JANX
Janux Therapeutics
$56.83
+0.1%
11/22/2024Initiated byLeerink Partners-Outperform$79.00N/AView details for Leerink Partners rating of Janux Therapeutics (NASDAQ:JANX) on 11/22/2024
AbbVie stock logo
ABBV
AbbVie
$175.58
+2.4%
11/22/2024Upgraded byLeerink Partners-Market Perform -> Outperform$206.00N/AView details for Leerink Partners rating of AbbVie (NYSE:ABBV) on 11/22/2024
IQVIA stock logo
IQV
IQVIA
$197.27
+3.0%
11/19/2024Reiterated byLeerink Partners-Outperform -> Outperform$260.00 -> $248.00N/AView details for Leerink Partners rating of IQVIA (NYSE:IQV) on 11/19/2024
Rocket Pharmaceuticals stock logo
RCKT
Rocket Pharmaceuticals
$11.56
+1.9%
11/19/2024Target Lowered byLeerink Partners-Outperform -> Outperform$46.00 -> $44.00N/AView details for Leerink Partners rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/19/2024
Enhabit stock logo
EHAB
Enhabit
$7.65
-0.6%
11/19/2024Reiterated byLeerink Partners-Market Perform -> Market Perform$8.50 -> $8.00N/AView details for Leerink Partners rating of Enhabit (NYSE:EHAB) on 11/19/2024
ICON Public stock logo
ICLR
ICON Public
$207.51
+1.4%
11/19/2024Reiterated byLeerink Partners-Outperform -> Outperform$270.00 -> $255.00N/AView details for Leerink Partners rating of ICON Public (NASDAQ:ICLR) on 11/19/2024
Aclaris Therapeutics stock logo
ACRS
Aclaris Therapeutics
$2.72
-1.8%
11/19/2024Upgraded byLeerink Partners-Market Perform -> Outperform$2.00 -> $7.00N/AView details for Leerink Partners rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024
Compass Therapeutics stock logo
CMPX
Compass Therapeutics
$1.38
+0.7%
11/15/2024Downgraded byLeerink Partners-Outperform -> Market Perform$5.00 -> $4.00N/AView details for Leerink Partners rating of Compass Therapeutics (NASDAQ:CMPX) on 11/15/2024
Lexeo Therapeutics stock logo
LXEO
Lexeo Therapeutics
$6.28
+4.0%
11/13/2024Target Lowered byLeerink Partners-Outperform -> Outperform$20.00 -> $19.00N/AView details for Leerink Partners rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/13/2024
908 Devices stock logo
MASS
908 Devices
$2.06
+6.2%
11/13/2024Reiterated byLeerink Partners-Outperform -> Market Perform$12.00 -> $4.00N/AView details for Leerink Partners rating of 908 Devices (NASDAQ:MASS) on 11/13/2024
Ardent Health Partners stock logo
ARDT
Ardent Health Partners
$16.01
-0.2%
11/12/2024Target Raised byLeerink Partners-Outperform -> Outperform$23.00 -> $25.00N/AView details for Leerink Partners rating of Ardent Health Partners (NYSE:ARDT) on 11/12/2024
Neurogene stock logo
NGNE
Neurogene
$22.64
+2.5%
11/12/2024Target Raised byLeerink Partners-Outperform -> Outperform$45.00 -> $72.00N/AView details for Leerink Partners rating of Neurogene (NASDAQ:NGNE) on 11/12/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$57.33
+1.8%
11/12/2024Upgraded byLeerink Partners-Market Perform -> Outperform$55.00 -> $73.00N/AView details for Leerink Partners rating of Bristol-Myers Squibb (NYSE:BMY) on 11/12/2024
Tectonic Therapeutic stock logo
TECX
Tectonic Therapeutic
$47.44
+7.7%
11/11/2024Target Raised byLeerink Partners-Outperform -> Outperform$49.00 -> $69.00N/AView details for Leerink Partners rating of Tectonic Therapeutic (NASDAQ:TECX) on 11/11/2024
DENTSPLY SIRONA stock logo
XRAY
DENTSPLY SIRONA
$18.70
+1.2%
11/7/2024Downgraded byLeerink Partners-Outperform -> Market PerformN/AView details for Leerink Partners rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 11/7/2024
Zymeworks stock logo
ZYME
Zymeworks
$14.14
+4.1%
11/7/2024Upgraded byLeerink Partners-Market Perform -> Outperform$10.00 -> $25.00N/AView details for Leerink Partners rating of Zymeworks (NYSE:ZYME) on 11/7/2024
Beam Therapeutics stock logo
BEAM
Beam Therapeutics
$29.01
+8.0%
11/6/2024Upgraded byLeerink Partners-Market Perform -> Outperform$27.00 -> $39.00N/AView details for Leerink Partners rating of Beam Therapeutics (NASDAQ:BEAM) on 11/6/2024
IDEAYA Biosciences stock logo
IDYA
IDEAYA Biosciences
$25.61
+3.3%
11/5/2024Downgraded byLeerink Partners-Outperform -> Market Perform$41.00 -> $27.00LowView details for Leerink Partners rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/5/2024
Zura Bio stock logo
ZURA
Zura Bio
$2.28
-2.6%
11/4/2024Initiated byLeerink Partners-Outperform$15.00HighView details for Leerink Partners rating of Zura Bio (NASDAQ:ZURA) on 11/4/2024
Envista stock logo
NVST
Envista
$18.70
+3.7%
10/31/2024Upgraded byLeerink Partners-Underperform -> Market Perform$16.00 -> $23.00HighView details for Leerink Partners rating of Envista (NYSE:NVST) on 10/31/2024
Aquestive Therapeutics stock logo
AQST
Aquestive Therapeutics
$3.65
+0.3%
10/25/2024Target Raised byLeerink Partners-Outperform -> Outperform$12.00 -> $13.00LowView details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 10/25/2024
DexCom stock logo
DXCM
DexCom
$80.04
+5.6%
10/25/2024Target Lowered byLeerink Partners-Outperform -> Outperform$90.00 -> $87.00HighView details for Leerink Partners rating of DexCom (NASDAQ:DXCM) on 10/25/2024
ICON Public stock logo
ICLR
ICON Public
$207.51
+1.4%
10/25/2024Target Lowered byLeerink Partners-Outperform -> Outperform$376.00 -> $270.00HighView details for Leerink Partners rating of ICON Public (NASDAQ:ICLR) on 10/25/2024
Tenax Therapeutics stock logo
TENX
Tenax Therapeutics
$5.61
+0.9%
10/24/2024Initiated byLeerink Partners-Outperform$16.00HighView details for Leerink Partners rating of Tenax Therapeutics (NASDAQ:TENX) on 10/24/2024
Gilead Sciences stock logo
GILD
Gilead Sciences
$92.57
+1.6%
10/21/2024Upgraded byLeerink Partners-Market Perform -> Outperform$74.00 -> $96.00LowView details for Leerink Partners rating of Gilead Sciences (NASDAQ:GILD) on 10/21/2024
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
Tenaya Therapeutics stock logo
TNYA
Tenaya Therapeutics
$1.67
+18.4%
10/18/2024Reiterated byLeerink Partners-Outperform -> OutperformLowView details for Leerink Partners rating of Tenaya Therapeutics (NASDAQ:TNYA) on 10/18/2024
Amylyx Pharmaceuticals stock logo
AMLX
Amylyx Pharmaceuticals
$4.05
+2.3%
10/18/2024Target Set byLeerink PartnersAnalyst Marc GoodmanMarket Perform -> Market Perform$4.00HighView details for Leerink Partners rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 10/18/2024
Lexicon Pharmaceuticals stock logo
LXRX
Lexicon Pharmaceuticals
$0.71
-1.2%
10/18/2024Target Set byLeerink PartnersAnalyst Roanna RuizOutperform -> Outperform$6.00LowView details for Leerink Partners rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 10/18/2024
Intuitive Surgical stock logo
ISRG
Intuitive Surgical
$524.43
+0.1%
10/17/2024Target Raised byLeerink Partners-$489.00 -> $502.00LowView details for Leerink Partners rating of Intuitive Surgical (NASDAQ:ISRG) on 10/17/2024
BridgeBio Pharma stock logo
BBIO
BridgeBio Pharma
$26.49
+1.1%
10/17/2024Target Lowered byLeerink Partners-Outperform -> Outperform$47.00 -> $46.00LowView details for Leerink Partners rating of BridgeBio Pharma (NASDAQ:BBIO) on 10/17/2024
Mirum Pharmaceuticals stock logo
MIRM
Mirum Pharmaceuticals
$41.51
+0.9%
10/17/2024Target Raised byLeerink Partners-Outperform -> Outperform$47.00 -> $49.00LowView details for Leerink Partners rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 10/17/2024
Illumina stock logo
ILMN
Illumina
$136.02
+1.5%
10/17/2024Target Raised byLeerink Partners-Outperform -> Outperform$160.00 -> $200.00LowView details for Leerink Partners rating of Illumina (NASDAQ:ILMN) on 10/17/2024
908 Devices stock logo
MASS
908 Devices
$2.06
+6.2%
10/17/2024Target Lowered byLeerink Partners-Outperform -> Outperform$15.00 -> $12.00MediumView details for Leerink Partners rating of 908 Devices (NASDAQ:MASS) on 10/17/2024
Natera stock logo
NTRA
Natera
$161.88
+2.4%
10/17/2024Target Raised byLeerink Partners-Outperform -> Outperform$140.00 -> $150.00MediumView details for Leerink Partners rating of Natera (NASDAQ:NTRA) on 10/17/2024
Revvity stock logo
RVTY
Revvity
$112.56
+1.8%
10/17/2024Target Raised byLeerink Partners-Outperform -> Outperform$130.00 -> $135.00LowView details for Leerink Partners rating of Revvity (NYSE:RVTY) on 10/17/2024
Twist Bioscience stock logo
TWST
Twist Bioscience
$47.94
+9.9%
10/17/2024Target Raised byLeerink Partners-Market Perform -> Market Perform$45.00 -> $48.00MediumView details for Leerink Partners rating of Twist Bioscience (NASDAQ:TWST) on 10/17/2024
Veracyte stock logo
VCYT
Veracyte
$40.89
+4.7%
10/17/2024Target Raised byLeerink Partners-Outperform -> Outperform$35.00 -> $40.00LowView details for Leerink Partners rating of Veracyte (NASDAQ:VCYT) on 10/17/2024
Guardant Health stock logo
GH
Guardant Health
$31.67
+1.7%
10/17/2024Target Lowered byLeerink Partners-Outperform -> Outperform$60.00 -> $50.00HighView details for Leerink Partners rating of Guardant Health (NASDAQ:GH) on 10/17/2024
Wave Life Sciences stock logo
WVE
Wave Life Sciences
$13.51
+2.4%
10/16/2024Target Raised byLeerink Partners-Outperform -> Outperform$20.00 -> $22.00HighView details for Leerink Partners rating of Wave Life Sciences (NASDAQ:WVE) on 10/16/2024
Voyager Therapeutics stock logo
VYGR
Voyager Therapeutics
$5.75
+1.1%
10/16/2024Initiated byLeerink Partners-Outperform$15.00HighView details for Leerink Partners rating of Voyager Therapeutics (NASDAQ:VYGR) on 10/16/2024
Mind Medicine (MindMed) stock logo
MNMD
Mind Medicine (MindMed)
$7.16
+2.1%
10/14/2024Initiated byLeerink Partners-Outperform$20.00HighView details for Leerink Partners rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 10/14/2024
Stoke Therapeutics stock logo
STOK
Stoke Therapeutics
$11.68
+3.4%
10/14/2024Initiated byLeerink Partners-Outperform$18.00HighView details for Leerink Partners rating of Stoke Therapeutics (NASDAQ:STOK) on 10/14/2024
Hologic stock logo
HOLX
Hologic
$71.65
+1.3%
10/8/2024Target Lowered byLeerink Partners-Outperform -> Outperform$95.00 -> $90.00LowView details for Leerink Partners rating of Hologic (NASDAQ:HOLX) on 10/8/2024
Travere Therapeutics stock logo
TVTX
Travere Therapeutics
$17.18
-1.3%
10/8/2024Reiterated byLeerink Partners-Outperform -> Outperform$20.00 -> $20.00MediumView details for Leerink Partners rating of Travere Therapeutics (NASDAQ:TVTX) on 10/8/2024
Cencora stock logo
COR
Cencora
$227.69
+0.6%
10/7/2024Target Lowered byLeerink Partners-Outperform -> Outperform$277.00 -> $275.00LowView details for Leerink Partners rating of Cencora (NYSE:COR) on 10/7/2024
McKesson stock logo
MCK
McKesson
$579.74
+0.1%
10/7/2024Target Lowered byLeerink Partners-Outperform -> Outperform$665.00 -> $630.00LowView details for Leerink Partners rating of McKesson (NYSE:MCK) on 10/7/2024
Humana stock logo
HUM
Humana
$247.10
+4.8%
10/2/2024Downgraded byLeerink Partners-Outperform -> Market Perform$400.00 -> $250.00HighView details for Leerink Partners rating of Humana (NYSE:HUM) on 10/2/2024
Aquestive Therapeutics stock logo
AQST
Aquestive Therapeutics
$3.65
+0.3%
9/30/2024Reiterated byLeerink Partners-Outperform -> Outperform$10.00 -> $12.00HighView details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/30/2024
Agios Pharmaceuticals stock logo
AGIO
Agios Pharmaceuticals
$35.42
-1.1%
9/27/2024Downgraded byLeerink Partners-Outperform -> Market Perform$60.00 -> $56.00HighView details for Leerink Partners rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 9/27/2024
Regeneron Pharmaceuticals stock logo
REGN
Regeneron Pharmaceuticals
$701.85
-0.9%
9/24/2024Reiterated byLeerink Partners-Outperform -> Market Perform$1,175.00 -> $1,077.00HighView details for Leerink Partners rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 9/24/2024
Biohaven stock logo
BHVN
Biohaven
$36.26
+2.6%
9/23/2024Target Raised byLeerink Partners-Outperform -> Outperform$55.00 -> $60.00LowView details for Leerink Partners rating of Biohaven (NYSE:BHVN) on 9/23/2024
ARS Pharmaceuticals stock logo
SPRY
ARS Pharmaceuticals
$11.18
-1.2%
9/20/2024Target Raised byLeerink Partners-Outperform -> Outperform$21.00 -> $25.00LowView details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/20/2024
Applied Therapeutics stock logo
APLT
Applied Therapeutics
$0.88
-13.7%
9/19/2024Target Raised byLeerink Partners-Outperform -> Outperform$11.00 -> $14.00LowView details for Leerink Partners rating of Applied Therapeutics (NASDAQ:APLT) on 9/19/2024
4D Molecular Therapeutics stock logo
FDMT
4D Molecular Therapeutics
$6.31
+9.2%
9/19/2024Reiterated byLeerink Partners-Outperform -> Outperform$40.00 -> $36.00HighView details for Leerink Partners rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/19/2024
Progyny stock logo
PGNY
Progyny
$14.34
+1.1%
9/19/2024Target Lowered byLeerink Partners-Market Perform -> Market Perform$25.00 -> $21.00HighView details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 9/19/2024
ICON Public stock logo
ICLR
ICON Public
$207.51
+1.4%
9/18/2024Initiated byLeerink Partners-Outperform$379.00HighView details for Leerink Partners rating of ICON Public (NASDAQ:ICLR) on 9/18/2024
Moderna stock logo
MRNA
Moderna
$39.39
-0.4%
9/17/2024Target Lowered byLeerink Partners-Underperform -> Underperform$60.00 -> $48.00MediumView details for Leerink Partners rating of Moderna (NASDAQ:MRNA) on 9/17/2024
Oruka Therapeutics stock logo
ORKA
Oruka Therapeutics
$20.31
-2.2%
9/17/2024Initiated byLeerink Partners-Outperform$44.00LowView details for Leerink Partners rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/17/2024
Fulcrum Therapeutics stock logo
FULC
Fulcrum Therapeutics
$4.35
+7.9%
9/12/2024Reiterated byLeerink Partners-Outperform -> Market Perform$4.00N/AView details for Leerink Partners rating of Fulcrum Therapeutics (NASDAQ:FULC) on 9/12/2024
Inspire Medical Systems stock logo
INSP
Inspire Medical Systems
$187.77
+1.3%
9/10/2024Target Raised byLeerink Partners-Market Perform -> Market Perform$167.00 -> $197.00LowView details for Leerink Partners rating of Inspire Medical Systems (NYSE:INSP) on 9/10/2024
MannKind stock logo
MNKD
MannKind
$6.85
+8.7%
9/9/2024Initiated byLeerink Partners-Outperform$7.00 -> $8.00MediumView details for Leerink Partners rating of MannKind (NASDAQ:MNKD) on 9/9/2024
Pliant Therapeutics stock logo
PLRX
Pliant Therapeutics
$13.21
-0.7%
9/9/2024Initiated byLeerink Partners-Outperform$46.00 -> $33.00LowView details for Leerink Partners rating of Pliant Therapeutics (NASDAQ:PLRX) on 9/9/2024
PureTech Health stock logo
PRTC
PureTech Health
$20.28
-3.8%
9/9/2024Initiated byLeerink Partners-Outperform$58.00 -> $45.00HighView details for Leerink Partners rating of PureTech Health (NASDAQ:PRTC) on 9/9/2024
Trevi Therapeutics stock logo
TRVI
Trevi Therapeutics
$4.05
-2.4%
9/9/2024Initiated byLeerink Partners-Outperform$6.00 -> $7.00HighView details for Leerink Partners rating of Trevi Therapeutics (NASDAQ:TRVI) on 9/9/2024
Immunic stock logo
IMUX
Immunic
$1.00
-3.8%
9/9/2024Reiterated byLeerink Partners-Outperform$5.00LowView details for Leerink Partners rating of Immunic (NASDAQ:IMUX) on 9/9/2024
Kymera Therapeutics stock logo
KYMR
Kymera Therapeutics
$40.66
+3.9%
9/9/2024Reiterated byLeerink Partners-Outperform$60.00MediumView details for Leerink Partners rating of Kymera Therapeutics (NASDAQ:KYMR) on 9/9/2024
Ironwood Pharmaceuticals stock logo
IRWD
Ironwood Pharmaceuticals
$4.45
+14.7%
9/9/2024Initiated byLeerink Partners-Market Perform$5.00HighView details for Leerink Partners rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/9/2024
Galapagos stock logo
GLPG
Galapagos
$26.76
+1.5%
9/9/2024Initiated byLeerink Partners-Market Perform$24.00HighView details for Leerink Partners rating of Galapagos (NASDAQ:GLPG) on 9/9/2024
Geron stock logo
GERN
Geron
$3.49
-4.6%
9/9/2024Initiated byLeerink Partners-Outperform$7.00MediumView details for Leerink Partners rating of Geron (NASDAQ:GERN) on 9/9/2024
McKesson stock logo
MCK
McKesson
$579.74
+0.1%
9/5/2024Target Lowered byLeerink Partners-Outperform -> Outperform$670.00 -> $665.00LowView details for Leerink Partners rating of McKesson (NYSE:MCK) on 9/5/2024
Vaxcyte stock logo
PCVX
Vaxcyte
$86.53
+0.4%
9/3/2024Target Raised byLeerink Partners-Outperform -> Outperform$106.00 -> $153.00LowView details for Leerink Partners rating of Vaxcyte (NASDAQ:PCVX) on 9/3/2024
Recursion Pharmaceuticals stock logo
RXRX
Recursion Pharmaceuticals
$6.03
-1.0%
9/3/2024Target Lowered byLeerink Partners-Market Perform -> Market Perform$9.00 -> $8.00LowView details for Leerink Partners rating of Recursion Pharmaceuticals (NASDAQ:RXRX) on 9/3/2024
Inari Medical stock logo
NARI
Inari Medical
$55.45
+1.9%
9/3/2024Initiated byLeerink Partners-Market Perform$47.00LowView details for Leerink Partners rating of Inari Medical (NASDAQ:NARI) on 9/3/2024
Penumbra stock logo
PEN
Penumbra
$242.54
-0.4%
9/3/2024Initiated byLeerink Partners-Outperform$263.00LowView details for Leerink Partners rating of Penumbra (NYSE:PEN) on 9/3/2024
10x Genomics stock logo
TXG
10x Genomics
$14.04
+3.2%
9/3/2024Initiated byLeerink Partners-Outperform$35.00LowView details for Leerink Partners rating of 10x Genomics (NASDAQ:TXG) on 9/3/2024
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
ARS Pharmaceuticals stock logo
SPRY
ARS Pharmaceuticals
$11.18
-1.2%
8/12/2024Target Raised byLeerink Partners-Outperform$19.00 -> $20.00LowView details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 8/12/2024
Ardent Health Partners stock logo
ARDT
Ardent Health Partners
$16.01
-0.2%
8/12/2024Initiated byLeerink Partners-Outperform$23.00LowView details for Leerink Partners rating of Ardent Health Partners (NYSE:ARDT) on 8/12/2024
Arcturus Therapeutics stock logo
ARCT
Arcturus Therapeutics
$15.48
+4.3%
8/12/2024Initiated byLeerink Partners-Outperform$70.00LowView details for Leerink Partners rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/12/2024
Progyny stock logo
PGNY
Progyny
$14.34
+1.1%
8/7/2024Downgraded byLeerink Partners-Outperform -> Market Perform$31.00 -> $25.00LowView details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 8/7/2024
Theravance Biopharma stock logo
TBPH
Theravance Biopharma
$9.59
-1.4%
8/6/2024Downgraded byLeerink Partners-Outperform -> Market Perform$15.00 -> $10.00LowView details for Leerink Partners rating of Theravance Biopharma (NASDAQ:TBPH) on 8/6/2024
Waters stock logo
WAT
Waters
$368.16
+2.1%
8/1/2024Upgraded byLeerink Partners-Market Perform -> Outperform$325.00 -> $375.00LowView details for Leerink Partners rating of Waters (NYSE:WAT) on 8/1/2024
Tectonic Therapeutic stock logo
TECX
Tectonic Therapeutic
$47.44
+7.7%
7/24/2024Initiated byLeerink Partners-Outperform$49.00LowView details for Leerink Partners rating of Tectonic Therapeutic (NASDAQ:TECX) on 7/24/2024
Danaher stock logo
DHR
Danaher
$228.55
+1.1%
7/24/2024Target Raised byLeerink Partners-Outperform$275.00 -> $280.00LowView details for Leerink Partners rating of Danaher (NYSE:DHR) on 7/24/2024
HCA Healthcare stock logo
HCA
HCA Healthcare
$303.62
+2.1%
7/24/2024Target Raised byLeerink Partners-Outperform -> Outperform$367.00 -> $396.00LowView details for Leerink Partners rating of HCA Healthcare (NYSE:HCA) on 7/24/2024
Ionis Pharmaceuticals stock logo
IONS
Ionis Pharmaceuticals
$35.63
+0.1%
7/24/2024Upgraded byLeerink Partners-Market Perform -> Outperform$53.00 -> $62.00LowView details for Leerink Partners rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/24/2024
Alumis stock logo
ALMS
Alumis
$8.82
+2.2%
7/23/2024Initiated byLeerink Partners-Outperform$29.00LowView details for Leerink Partners rating of Alumis (NASDAQ:ALMS) on 7/23/2024
Celcuity stock logo
CELC
Celcuity
$12.46
+3.8%
7/22/2024Initiated byLeerink Partners-Outperform$29.00LowView details for Leerink Partners rating of Celcuity (NASDAQ:CELC) on 7/22/2024
Benitec Biopharma stock logo
BNTC
Benitec Biopharma
$11.41
-6.2%
7/22/2024Initiated byLeerink Partners-Outperform$13.00LowView details for Leerink Partners rating of Benitec Biopharma (NASDAQ:BNTC) on 7/22/2024
Lantheus stock logo
LNTH
Lantheus
$89.29
-2.9%
7/11/2024Target Raised byLeerink Partners-Outperform -> Outperform$106.00 -> $127.00LowView details for Leerink Partners rating of Lantheus (NASDAQ:LNTH) on 7/11/2024
Encompass Health stock logo
EHC
Encompass Health
$94.45
+0.7%
7/10/2024Initiated byLeerink Partners-Outperform$100.00LowView details for Leerink Partners rating of Encompass Health (NYSE:EHC) on 7/10/2024
HilleVax stock logo
HLVX
HilleVax
$1.86
+1.6%
7/9/2024Downgraded byLeerink Partners-Outperform -> Market Perform$28.00 -> $2.00LowView details for Leerink Partners rating of HilleVax (NASDAQ:HLVX) on 7/9/2024
Revvity stock logo
RVTY
Revvity
$112.56
+1.8%
7/8/2024Initiated byLeerink Partners-Outperform$125.00LowView details for Leerink Partners rating of Revvity (NYSE:RVTY) on 7/8/2024
Schrödinger stock logo
SDGR
Schrödinger
$19.44
+0.7%
7/2/2024Initiated byLeerink Partners-Outperform$29.00LowView details for Leerink Partners rating of Schrödinger (NASDAQ:SDGR) on 7/2/2024
Cencora stock logo
COR
Cencora
$227.69
+0.6%
6/27/2024Reiterated byLeerink Partners-Outperform -> Outperform$275.00 -> $275.00LowView details for Leerink Partners rating of Cencora (NYSE:COR) on 6/27/2024
Alnylam Pharmaceuticals stock logo
ALNY
Alnylam Pharmaceuticals
$245.44
+2.8%
6/25/2024Target Raised byLeerink Partners-Market Perform -> Market Perform$138.00 -> $159.00LowView details for Leerink Partners rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 6/25/2024
Solid Biosciences stock logo
SLDB
Solid Biosciences
$4.16
+3.7%
6/24/2024Upgraded byLeerink Partners-Market Perform -> Outperform$12.00 -> $12.00LowView details for Leerink Partners rating of Solid Biosciences (NASDAQ:SLDB) on 6/24/2024
Sarepta Therapeutics stock logo
SRPT
Sarepta Therapeutics
$118.97
-0.4%
6/24/2024Target Raised byLeerink Partners-Outperform -> Outperform$165.00 -> $230.00LowView details for Leerink Partners rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/24/2024
Mereo BioPharma Group stock logo
MREO
Mereo BioPharma Group
$3.35
+1.8%
6/20/2024Target Raised byLeerink Partners-Outperform -> Outperform$6.00 -> $8.00LowView details for Leerink Partners rating of Mereo BioPharma Group (NASDAQ:MREO) on 6/20/2024
Q32 Bio stock logo
QTTB
Q32 Bio
$3.59
+7.5%
5/21/2024Initiated byLeerink Partners-Outperform$54.00LowView details for Leerink Partners rating of Q32 Bio (NASDAQ:QTTB) on 5/21/2024
Bolt Biotherapeutics stock logo
BOLT
Bolt Biotherapeutics
$0.50
-0.7%
5/15/2024Reiterated byLeerink Partners-Outperform -> Market Perform$3.00 -> $1.00LowView details for Leerink Partners rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/15/2024
AirSculpt Technologies stock logo
AIRS
AirSculpt Technologies
$5.35
-2.6%
5/14/2024Downgraded byLeerink Partners-Outperform -> Market Perform$8.25 -> $5.00LowView details for Leerink Partners rating of AirSculpt Technologies (NASDAQ:AIRS) on 5/14/2024
Enhabit stock logo
EHAB
Enhabit
$7.65
-0.6%
5/14/2024Upgraded byLeerink Partners-Underperform -> Market Perform$8.50LowView details for Leerink Partners rating of Enhabit (NYSE:EHAB) on 5/14/2024
Aquestive Therapeutics stock logo
AQST
Aquestive Therapeutics
$3.65
+0.3%
5/10/2024Initiated byLeerink Partners-Outperform$8.00LowView details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/10/2024
Myriad Genetics stock logo
MYGN
Myriad Genetics
$13.36
+1.4%
5/8/2024Upgraded byLeerink Partners-Market Perform -> Outperform$25.00 -> $35.00LowView details for Leerink Partners rating of Myriad Genetics (NASDAQ:MYGN) on 5/8/2024
Blueprint Medicines stock logo
BPMC
Blueprint Medicines
$90.14
+1.4%
5/6/2024Upgraded byLeerink Partners-Underperform -> Market Perform$50.00 -> $97.00LowView details for Leerink Partners rating of Blueprint Medicines (NASDAQ:BPMC) on 5/6/2024
CVS Health stock logo
CVS
CVS Health
$44.36
+1.3%
5/1/2024Reiterated byLeerink Partners-Outperform -> Market Perform$87.00 -> $60.00LowView details for Leerink Partners rating of CVS Health (NYSE:CVS) on 5/1/2024
Lexicon Pharmaceuticals stock logo
LXRX
Lexicon Pharmaceuticals
$0.71
-1.2%
4/30/2024Initiated byLeerink Partners-Outperform$5.00LowView details for Leerink Partners rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 4/30/2024
XOMA stock logo
XOMA
XOMA
$27.13
+8.0%
4/29/2024Initiated byLeerink Partners-Outperform$40.00LowView details for Leerink Partners rating of XOMA (NASDAQ:XOMA) on 4/29/2024
Neurogene stock logo
NGNE
Neurogene
$22.64
+2.5%
4/29/2024Initiated byLeerink Partners-Outperform$46.00LowView details for Leerink Partners rating of Neurogene (NASDAQ:NGNE) on 4/29/2024
Immunocore stock logo
IMCR
Immunocore
$28.33
-0.3%
4/29/2024Initiated byLeerink Partners-Outperform$74.00LowView details for Leerink Partners rating of Immunocore (NASDAQ:IMCR) on 4/29/2024
CureVac stock logo
CVAC
CureVac
$2.87
-4.0%
4/25/2024Downgraded byLeerink Partners-Outperform -> Market Perform$12.00 -> $4.00LowView details for Leerink Partners rating of CureVac (NASDAQ:CVAC) on 4/25/2024
Tandem Diabetes Care stock logo
TNDM
Tandem Diabetes Care
$35.91
+7.9%
4/25/2024Upgraded byLeerink Partners-Market Perform -> Outperform$34.00 -> $45.00LowView details for Leerink Partners rating of Tandem Diabetes Care (NASDAQ:TNDM) on 4/25/2024
Cartesian Therapeutics stock logo
RNAC
Cartesian Therapeutics
$19.02
-1.3%
4/23/2024Initiated byLeerink Partners-Outperform$39.00LowView details for Leerink Partners rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024
AnaptysBio stock logo
ANAB
AnaptysBio
$14.55
-3.0%
4/16/2024Initiated byLeerink Partners-Outperform$47.00LowView details for Leerink Partners rating of AnaptysBio (NASDAQ:ANAB) on 4/16/2024
Mind Medicine (MindMed) stock logo
MNMD
Mind Medicine (MindMed)
$7.16
+2.1%
4/15/2024Initiated byLeerink Partners-Outperform$20.00LowView details for Leerink Partners rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 4/15/2024
LENZ Therapeutics stock logo
LENZ
LENZ Therapeutics
$32.63
+7.8%
4/15/2024Initiated byLeerink Partners-Outperform$32.00LowView details for Leerink Partners rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/15/2024
Ardelyx stock logo
ARDX
Ardelyx
$4.82
+2.8%
4/5/2024Initiated byLeerink Partners-Outperform$14.00LowView details for Leerink Partners rating of Ardelyx (NASDAQ:ARDX) on 4/5/2024
Larimar Therapeutics stock logo
LRMR
Larimar Therapeutics
$4.01
+0.8%
4/3/2024Initiated byLeerink Partners-Outperform$25.00LowView details for Leerink Partners rating of Larimar Therapeutics (NASDAQ:LRMR) on 4/3/2024
Nuvalent stock logo
NUVL
Nuvalent
$84.22
-0.5%
4/1/2024Upgraded byLeerink Partners-Market Perform -> Outperform$69.00 -> $110.00LowView details for Leerink Partners rating of Nuvalent (NASDAQ:NUVL) on 4/1/2024
Sagimet Biosciences stock logo
SGMT
Sagimet Biosciences
$4.95
-2.4%
3/25/2024Initiated byLeerink Partners-Outperform$26.00LowView details for Leerink Partners rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/25/2024
Walgreens Boots Alliance stock logo
WBA
Walgreens Boots Alliance
$9.55
+2.1%
3/18/2024Target Lowered byLeerink Partners-Market Perform -> Market Perform$23.00 -> $22.00LowView details for Leerink Partners rating of Walgreens Boots Alliance (NASDAQ:WBA) on 3/18/2024
Mirum Pharmaceuticals stock logo
MIRM
Mirum Pharmaceuticals
$41.51
+0.9%
3/18/2024Target Lowered byLeerink Partners-Outperform -> Outperform$44.00 -> $43.00LowView details for Leerink Partners rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 3/18/2024
Regulus Therapeutics stock logo
RGLS
Regulus Therapeutics
$1.59
+2.6%
3/18/2024Initiated byLeerink Partners-Outperform$6.00LowView details for Leerink Partners rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/18/2024
Spruce Biosciences stock logo
SPRB
Spruce Biosciences
$0.40
+4.7%
3/14/2024Downgraded byLeerink Partners-Outperform -> Market Perform$9.00 -> $2.00LowView details for Leerink Partners rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024
Amylyx Pharmaceuticals stock logo
AMLX
Amylyx Pharmaceuticals
$4.05
+2.3%
3/11/2024Downgraded byLeerink Partners-Outperform -> Market PerformLowView details for Leerink Partners rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/11/2024
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
REGENXBIO stock logo
RGNX
REGENXBIO
$7.62
+2.8%
3/6/2024Upgraded byLeerink Partners-Market Perform -> Outperform$37.00LowView details for Leerink Partners rating of REGENXBIO (NASDAQ:RGNX) on 3/6/2024
ARS Pharmaceuticals stock logo
SPRY
ARS Pharmaceuticals
$11.18
-1.2%
3/5/2024Upgraded byLeerink Partners-Market Perform -> Outperform$6.00 -> $18.00LowView details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/5/2024
Kyverna Therapeutics stock logo
KYTX
Kyverna Therapeutics
$4.00
+3.4%
3/4/2024Initiated byLeerink Partners-Outperform$48.00LowView details for Leerink Partners rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024
Walgreens Boots Alliance stock logo
WBA
Walgreens Boots Alliance
$9.55
+2.1%
2/26/2024Initiated byLeerink Partners-Market Perform$23.00LowView details for Leerink Partners rating of Walgreens Boots Alliance (NASDAQ:WBA) on 2/26/2024
DENTSPLY SIRONA stock logo
XRAY
DENTSPLY SIRONA
$18.70
+1.2%
2/26/2024Initiated byLeerink Partners-Outperform$42.00LowView details for Leerink Partners rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 2/26/2024
Progyny stock logo
PGNY
Progyny
$14.34
+1.1%
2/26/2024Initiated byLeerink Partners-Outperform$49.00LowView details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 2/26/2024
Premier stock logo
PINC
Premier
$21.76
+1.2%
2/26/2024Initiated byLeerink Partners-Market Perform$22.50LowView details for Leerink Partners rating of Premier (NASDAQ:PINC) on 2/26/2024
Patterson Companies stock logo
PDCO
Patterson Companies
$30.86
-0.2%
2/26/2024Initiated byLeerink Partners-Outperform$36.00LowView details for Leerink Partners rating of Patterson Companies (NASDAQ:PDCO) on 2/26/2024
Owens & Minor stock logo
OMI
Owens & Minor
$12.52
-0.8%
2/26/2024Initiated byLeerink Partners-Market Perform$24.00LowView details for Leerink Partners rating of Owens & Minor (NYSE:OMI) on 2/26/2024
McKesson stock logo
MCK
McKesson
$579.74
+0.1%
2/26/2024Initiated byLeerink Partners-Outperform$600.00LowView details for Leerink Partners rating of McKesson (NYSE:MCK) on 2/26/2024
Laboratory Co. of America stock logo
LH
Laboratory Co. of America
$228.61
+0.7%
2/26/2024Initiated byLeerink Partners-Outperform$260.00LowView details for Leerink Partners rating of Laboratory Co. of America (NYSE:LH) on 2/26/2024
IQVIA stock logo
IQV
IQVIA
$197.27
+3.0%
2/26/2024Initiated byLeerink Partners-Outperform$290.00LowView details for Leerink Partners rating of IQVIA (NYSE:IQV) on 2/26/2024
Hims & Hers Health stock logo
HIMS
Hims & Hers Health
$26.20
-0.6%
2/26/2024Initiated byLeerink Partners-Market Perform$10.00LowView details for Leerink Partners rating of Hims & Hers Health (NYSE:HIMS) on 2/26/2024
GoodRx stock logo
GDRX
GoodRx
$4.44
-1.1%
2/26/2024Initiated byLeerink Partners-Outperform$8.00LowView details for Leerink Partners rating of GoodRx (NASDAQ:GDRX) on 2/26/2024
Envista stock logo
NVST
Envista
$18.70
+3.7%
2/26/2024Initiated byLeerink Partners-Underperform$19.00LowView details for Leerink Partners rating of Envista (NYSE:NVST) on 2/26/2024
Teladoc Health stock logo
TDOC
Teladoc Health
$9.44
+5.2%
2/26/2024Initiated byLeerink Partners-Market Perform$17.00LowView details for Leerink Partners rating of Teladoc Health (NYSE:TDOC) on 2/26/2024
CVS Health stock logo
CVS
CVS Health
$44.36
+1.3%
2/26/2024Initiated byLeerink Partners-Outperform$88.00LowView details for Leerink Partners rating of CVS Health (NYSE:CVS) on 2/26/2024
Henry Schein stock logo
HSIC
Henry Schein
$69.82
+1.3%
2/26/2024Initiated byLeerink Partners-Market Perform$78.00LowView details for Leerink Partners rating of Henry Schein (NASDAQ:HSIC) on 2/26/2024
Quest Diagnostics stock logo
DGX
Quest Diagnostics
$153.10
+1.0%
2/26/2024Initiated byLeerink Partners-Market Perform$135.00LowView details for Leerink Partners rating of Quest Diagnostics (NYSE:DGX) on 2/26/2024
Doximity stock logo
DOCS
Doximity
$57.83
+4.8%
2/26/2024Initiated byLeerink Partners-Market Perform$32.00LowView details for Leerink Partners rating of Doximity (NASDAQ:DOCS) on 2/26/2024
Certara stock logo
CERT
Certara
$10.71
+1.5%
2/26/2024Initiated byLeerink Partners-Market Perform$19.00LowView details for Leerink Partners rating of Certara (NASDAQ:CERT) on 2/26/2024
Cencora stock logo
COR
Cencora
$227.69
+0.6%
2/26/2024Initiated byLeerink Partners-Outperform$261.00LowView details for Leerink Partners rating of Cencora (NYSE:COR) on 2/26/2024
Cardinal Health stock logo
CAH
Cardinal Health
$118.28
+1.1%
2/26/2024Initiated byLeerink Partners-Outperform$125.00LowView details for Leerink Partners rating of Cardinal Health (NYSE:CAH) on 2/26/2024
Align Technology stock logo
ALGN
Align Technology
$211.06
-1.2%
2/26/2024Initiated byLeerink Partners-Market Perform$310.00LowView details for Leerink Partners rating of Align Technology (NASDAQ:ALGN) on 2/26/2024
Accolade stock logo
ACCD
Accolade
$3.48
+4.8%
2/26/2024Initiated byLeerink Partners-Outperform$16.00LowView details for Leerink Partners rating of Accolade (NASDAQ:ACCD) on 2/26/2024
Applied Therapeutics stock logo
APLT
Applied Therapeutics
$0.88
-13.7%
2/22/2024Initiated byLeerink Partners-Outperform$12.00LowView details for Leerink Partners rating of Applied Therapeutics (NASDAQ:APLT) on 2/22/2024
RAPT Therapeutics stock logo
RAPT
RAPT Therapeutics
$0.83
+2.2%
2/21/2024Downgraded byLeerink Partners-Outperform -> Market Perform$42.00 -> $10.00LowView details for Leerink Partners rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/21/2024
BrightSpring Health Services stock logo
BTSG
BrightSpring Health Services
$17.27
+1.3%
2/20/2024Initiated byLeerink Partners-Outperform$15.00LowView details for Leerink Partners rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024
enGene stock logo
ENGN
enGene
$5.83
-2.2%
2/20/2024Initiated byLeerink Partners-Outperform$31.00LowView details for Leerink Partners rating of enGene (NASDAQ:ENGN) on 2/20/2024
Synlogic stock logo
SYBX
Synlogic
$1.42
+3.5%
2/9/2024Reiterated byLeerink Partners-Outperform -> Market PerformLowView details for Leerink Partners rating of Synlogic (NASDAQ:SYBX) on 2/9/2024
Amgen stock logo
AMGN
Amgen
$263.38
+0.8%
2/7/2024Downgraded byLeerink Partners-Outperform -> Market Perform$324.00 -> $318.00LowView details for Leerink Partners rating of Amgen (NASDAQ:AMGN) on 2/7/2024
United Therapeutics stock logo
UTHR
United Therapeutics
$359.58
-0.2%
2/5/2024Initiated byLeerink Partners-Outperform$330.00LowView details for Leerink Partners rating of United Therapeutics (NASDAQ:UTHR) on 2/5/2024
2seventy bio stock logo
TSVT
2seventy bio
$3.14
+7.5%
1/31/2024Upgraded byLeerink Partners-Market Perform -> Outperform$5.00 -> $18.00LowView details for Leerink Partners rating of 2seventy bio (NASDAQ:TSVT) on 1/31/2024
NeuroPace stock logo
NPCE
NeuroPace
$11.53
+3.5%
1/30/2024Initiated byLeerink Partners-Outperform$22.00LowView details for Leerink Partners rating of NeuroPace (NASDAQ:NPCE) on 1/30/2024
Immunome stock logo
IMNM
Immunome
$10.97
-1.0%
1/29/2024Initiated byLeerink Partners-Outperform$30.00LowView details for Leerink Partners rating of Immunome (NASDAQ:IMNM) on 1/29/2024
Pyxis Oncology stock logo
PYXS
Pyxis Oncology
$1.69
+9.7%
1/23/2024Initiated byLeerink Partners-Outperform$12.00LowView details for Leerink Partners rating of Pyxis Oncology (NASDAQ:PYXS) on 1/23/2024
agilon health stock logo
AGL
agilon health
$1.97
+4.8%
1/8/2024Downgraded byLeerink Partners-Outperform -> Market PerformLowView details for Leerink Partners rating of agilon health (NYSE:AGL) on 1/8/2024
AlloVir stock logo
ALVR
AlloVir
$0.40
-10.2%
12/22/2023Downgraded byLeerink Partners-Outperform -> Market PerformLowView details for Leerink Partners rating of AlloVir (NASDAQ:ALVR) on 12/22/2023
Wave Life Sciences stock logo
WVE
Wave Life Sciences
$13.51
+2.4%
12/19/2023Upgraded byLeerink Partners-Market Perform -> Outperform$5.00 -> $12.00LowView details for Leerink Partners rating of Wave Life Sciences (NASDAQ:WVE) on 12/19/2023
Incyte stock logo
INCY
Incyte
$68.84
+2.7%
12/13/2023Upgraded byLeerink Partners-Market Perform -> Outperform$78.00LowView details for Leerink Partners rating of Incyte (NASDAQ:INCY) on 12/13/2023
Nanobiotix stock logo
NBTX
Nanobiotix
$3.10
-5.5%
12/8/2023Initiated byLeerink Partners-Outperform$11.00LowView details for Leerink Partners rating of Nanobiotix (NASDAQ:NBTX) on 12/8/2023
Tenaya Therapeutics stock logo
TNYA
Tenaya Therapeutics
$1.67
+18.4%
11/30/2023Initiated byLeerink Partners-Outperform$7.00LowView details for Leerink Partners rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/30/2023
Lexeo Therapeutics stock logo
LXEO
Lexeo Therapeutics
$6.28
+4.0%
11/28/2023Initiated byLeerink Partners-Outperform$19.00LowView details for Leerink Partners rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$7.65
-1.4%
11/14/2023Initiated byLeerink Partners-Outperform$20.00LowView details for Leerink Partners rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 11/14/2023
Zentalis Pharmaceuticals stock logo
ZNTL
Zentalis Pharmaceuticals
$3.00
+2.4%
11/7/2023Downgraded byLeerink Partners-Outperform -> Market Perform$15.00LowView details for Leerink Partners rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/7/2023
2seventy bio stock logo
TSVT
2seventy bio
$3.14
+7.5%
10/30/2023Downgraded byLeerink Partners-Outperform -> Market Perform$6.00LowView details for Leerink Partners rating of 2seventy bio (NASDAQ:TSVT) on 10/30/2023
Beam Therapeutics stock logo
BEAM
Beam Therapeutics
$29.01
+8.0%
10/20/2023Downgraded byLeerink Partners-Outperform -> Market Perform$75.00 -> $20.00LowView details for Leerink Partners rating of Beam Therapeutics (NASDAQ:BEAM) on 10/20/2023
4D Molecular Therapeutics stock logo
FDMT
4D Molecular Therapeutics
$6.31
+9.2%
10/18/2023Upgraded byLeerink Partners-Market Perform -> Outperform$24.00LowView details for Leerink Partners rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/18/2023
AxoGen stock logo
AXGN
AxoGen
$15.64
+5.3%
10/16/2023Initiated byLeerink Partners-Outperform$9.00LowView details for Leerink Partners rating of AxoGen (NASDAQ:AXGN) on 10/16/2023
PROCEPT BioRobotics stock logo
PRCT
PROCEPT BioRobotics
$81.17
+0.5%
10/16/2023Initiated byLeerink Partners-Outperform$37.00LowView details for Leerink Partners rating of PROCEPT BioRobotics (NASDAQ:PRCT) on 10/16/2023
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
DexCom stock logo
DXCM
DexCom
$80.04
+5.6%
10/16/2023Initiated byLeerink Partners-Outperform$110.00LowView details for Leerink Partners rating of DexCom (NASDAQ:DXCM) on 10/16/2023
Edwards Lifesciences stock logo
EW
Edwards Lifesciences
$74.81
+1.2%
10/16/2023Initiated byLeerink Partners-Market Perform$75.00LowView details for Leerink Partners rating of Edwards Lifesciences (NYSE:EW) on 10/16/2023
Inspire Medical Systems stock logo
INSP
Inspire Medical Systems
$187.77
+1.3%
10/16/2023Initiated byLeerink Partners-Market Perform$159.00LowView details for Leerink Partners rating of Inspire Medical Systems (NYSE:INSP) on 10/16/2023
Tandem Diabetes Care stock logo
TNDM
Tandem Diabetes Care
$35.91
+7.9%
10/16/2023Initiated byLeerink Partners-Market Perform$21.00LowView details for Leerink Partners rating of Tandem Diabetes Care (NASDAQ:TNDM) on 10/16/2023
Intuitive Surgical stock logo
ISRG
Intuitive Surgical
$524.43
+0.1%
10/16/2023Initiated byLeerink Partners-Outperform$342.00LowView details for Leerink Partners rating of Intuitive Surgical (NASDAQ:ISRG) on 10/16/2023
Vericel stock logo
VCEL
Vericel
$56.50
+2.8%
10/16/2023Initiated byLeerink Partners-Outperform$42.00LowView details for Leerink Partners rating of Vericel (NASDAQ:VCEL) on 10/16/2023
Insulet stock logo
PODD
Insulet
$266.57
+3.9%
10/16/2023Initiated byLeerink Partners-Outperform$184.00LowView details for Leerink Partners rating of Insulet (NASDAQ:PODD) on 10/16/2023
Amgen stock logo
AMGN
Amgen
$263.38
+0.8%
10/11/2023Upgraded byLeerink Partners-Market Perform -> Outperform$267.00 -> $318.00LowView details for Leerink Partners rating of Amgen (NASDAQ:AMGN) on 10/11/2023
Neurocrine Biosciences stock logo
NBIX
Neurocrine Biosciences
$135.42
+0.3%
10/6/2023Target Raised byLeerink PartnersAnalyst M. Goodman$125.00 -> $135.00LowView details for Leerink Partners rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2023
Structure Therapeutics stock logo
GPCR
Structure Therapeutics
$27.90
-6.9%
9/29/2023Target Raised byLeerink Partners-$46.00 -> $97.00LowView details for Leerink Partners rating of Structure Therapeutics (NASDAQ:GPCR) on 9/29/2023
ARS Pharmaceuticals stock logo
SPRY
ARS Pharmaceuticals
$11.18
-1.2%
9/21/2023Downgraded byLeerink Partners-Outperform -> Market PerformLowView details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/21/2023
PTC Therapeutics stock logo
PTCT
PTC Therapeutics
$46.24
+2.2%
9/18/2023Target Lowered byLeerink PartnersAnalyst J. Schwartz$44.00 -> $30.00LowView details for Leerink Partners rating of PTC Therapeutics (NASDAQ:PTCT) on 9/18/2023
Spruce Biosciences stock logo
SPRB
Spruce Biosciences
$0.40
+4.7%
9/8/2023Upgraded byLeerink Partners-Market Perform -> Outperform$3.00 -> $9.00LowView details for Leerink Partners rating of Spruce Biosciences (NASDAQ:SPRB) on 9/8/2023
Design Therapeutics stock logo
DSGN
Design Therapeutics
$6.25
+4.3%
8/15/2023Reiterated byLeerink Partners-Outperform -> Market Perform$6.00LowView details for Leerink Partners rating of Design Therapeutics (NASDAQ:DSGN) on 8/15/2023
Cytokinetics stock logo
CYTK
Cytokinetics
$48.87
+4.6%
8/15/2023Initiated byLeerink Partners-Outperform$58.00LowView details for Leerink Partners rating of Cytokinetics (NASDAQ:CYTK) on 8/15/2023
Exelixis stock logo
EXEL
Exelixis
$33.29
-1.2%
8/8/2023Initiated byLeerink Partners-Market Perform$18.00LowView details for Leerink Partners rating of Exelixis (NASDAQ:EXEL) on 8/8/2023
IDEAYA Biosciences stock logo
IDYA
IDEAYA Biosciences
$25.61
+3.3%
8/8/2023Initiated byLeerink Partners-Outperform$33.00LowView details for Leerink Partners rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/8/2023
Nuvalent stock logo
NUVL
Nuvalent
$84.22
-0.5%
8/8/2023Initiated byLeerink Partners-Market Perform$42.00LowView details for Leerink Partners rating of Nuvalent (NASDAQ:NUVL) on 8/8/2023
NovoCure stock logo
NVCR
NovoCure
$30.80
+1.3%
8/4/2023Initiated byLeerink Partners-Outperform$51.00LowView details for Leerink Partners rating of NovoCure (NASDAQ:NVCR) on 8/4/2023
Belite Bio stock logo
BLTE
Belite Bio
$64.12
+1.1%
7/26/2023Reiterated byLeerink PartnersAnalyst M. GoodmanOutperform$25.00LowView details for Leerink Partners rating of Belite Bio (NASDAQ:BLTE) on 7/26/2023
Neurocrine Biosciences stock logo
NBIX
Neurocrine Biosciences
$135.42
+0.3%
7/24/2023Upgraded byLeerink PartnersAnalyst M. GoodmanMarket Perform -> OutperformLowView details for Leerink Partners rating of Neurocrine Biosciences (NASDAQ:NBIX) on 7/24/2023
Cryoport stock logo
CYRX
Cryoport
$7.86
+1.6%
7/13/2023Downgraded byLeerink PartnersAnalyst P. SoudaOutperform -> Market PerformLowView details for Leerink Partners rating of Cryoport (NASDAQ:CYRX) on 7/13/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$57.33
+1.8%
7/10/2023Reiterated byLeerink PartnersAnalyst D. RisingerMarket PerformLowView details for Leerink Partners rating of Bristol-Myers Squibb (NYSE:BMY) on 7/10/2023
Enhabit stock logo
EHAB
Enhabit
$7.65
-0.6%
6/20/2023Reiterated byLeerink PartnersAnalyst W. MayoUnderperformLowView details for Leerink Partners rating of Enhabit (NYSE:EHAB) on 6/20/2023
Oculis stock logo
OCS
Oculis
$16.98
-0.2%
6/12/2023Reiterated byLeerink PartnersAnalyst M. GoodmanOutperformLowView details for Leerink Partners rating of Oculis (NASDAQ:OCS) on 6/12/2023
Blueprint Medicines stock logo
BPMC
Blueprint Medicines
$90.14
+1.4%
6/5/2023Downgraded byLeerink PartnersAnalyst A. BerensMarket Perform -> UnderperformLowView details for Leerink Partners rating of Blueprint Medicines (NASDAQ:BPMC) on 6/5/2023
Elevation Oncology stock logo
ELEV
Elevation Oncology
$0.58
-7.3%
5/30/2023Upgraded byLeerink PartnersAnalyst A. BerensMarket Perform -> OutperformLowView details for Leerink Partners rating of Elevation Oncology (NASDAQ:ELEV) on 5/30/2023
Bolt Biotherapeutics stock logo
BOLT
Bolt Biotherapeutics
$0.50
-0.7%
5/12/2023Upgraded byLeerink PartnersAnalyst D. GrayboschMarket Perform -> OutperformLowView details for Leerink Partners rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/12/2023
Arrowhead Pharmaceuticals stock logo
ARWR
Arrowhead Pharmaceuticals
$19.45
-0.3%
5/12/2023Downgraded byLeerink PartnersAnalyst M. ForooharOutperform -> Market PerformLowView details for Leerink Partners rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/12/2023
Danaher stock logo
DHR
Danaher
$228.55
+1.1%
5/1/2023Reiterated byLeerink PartnersAnalyst P. SoudaOutperformLowView details for Leerink Partners rating of Danaher (NYSE:DHR) on 5/1/2023
Prothena stock logo
PRTA
Prothena
$15.22
-4.9%
4/24/2023Reiterated byLeerink PartnersAnalyst R. LiOutperformLowView details for Leerink Partners rating of Prothena (NASDAQ:PRTA) on 4/24/2023
Genfit stock logo
GNFT
Genfit
$3.80
+2.2%
4/14/2023Reiterated byLeerink PartnersAnalyst T. SmithOutperformLowView details for Leerink Partners rating of Genfit (NASDAQ:GNFT) on 4/14/2023
Connect Biopharma stock logo
CNTB
Connect Biopharma
$0.95
-4.2%
4/12/2023Reiterated byLeerink PartnersAnalyst T. SmithOutperformLowView details for Leerink Partners rating of Connect Biopharma (NASDAQ:CNTB) on 4/12/2023
Arrowhead Pharmaceuticals stock logo
ARWR
Arrowhead Pharmaceuticals
$19.45
-0.3%
4/12/2023Upgraded byLeerink PartnersAnalyst M. ForooharMarket Perform -> OutperformLowView details for Leerink Partners rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 4/12/2023
Corcept Therapeutics stock logo
CORT
Corcept Therapeutics
$51.40
+0.5%
4/11/2023Reiterated byLeerink PartnersAnalyst R. RuizMarket Perform$25.00LowView details for Leerink Partners rating of Corcept Therapeutics (NASDAQ:CORT) on 4/11/2023
Arcellx stock logo
ACLX
Arcellx
$75.54
+0.4%
3/30/2023Target Raised byLeerink Partners-Outperform$35.00 -> $39.00LowView details for Leerink Partners rating of Arcellx (NASDAQ:ACLX) on 3/30/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$114.23
+1.6%
3/31/2023Target Raised byLeerink Partners-Market Perform$90.00 -> $102.00LowView details for Leerink Partners rating of Abbott Laboratories (NYSE:ABT) on 3/31/2023
Regeneron Pharmaceuticals stock logo
REGN
Regeneron Pharmaceuticals
$701.85
-0.9%
3/27/2023Upgraded byLeerink PartnersAnalyst D. RisingerMarket Perform -> OutperformLowView details for Leerink Partners rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 3/27/2023
PTC Therapeutics stock logo
PTCT
PTC Therapeutics
$46.24
+2.2%
3/17/2023Reiterated byLeerink PartnersAnalyst J. SchwartzMarket Perform$48.00LowView details for Leerink Partners rating of PTC Therapeutics (NASDAQ:PTCT) on 3/17/2023
Centessa Pharmaceuticals stock logo
CNTA
Centessa Pharmaceuticals
$17.16
-2.2%
3/17/2023Reiterated byLeerink PartnersAnalyst D. RisingerOutperform$6.00LowView details for Leerink Partners rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/17/2023
Halozyme Therapeutics stock logo
HALO
Halozyme Therapeutics
$46.96
-0.8%
3/16/2023Downgraded byLeerink PartnersAnalyst D. RisingerOutperform -> Market Perform$42.00LowView details for Leerink Partners rating of Halozyme Therapeutics (NASDAQ:HALO) on 3/16/2023
argenx stock logo
ARGX
argenx
$623.82
-0.4%
3/3/2023Target Raised byLeerink Partners-Outperform$430.00 -> $435.00LowView details for Leerink Partners rating of argenx (NASDAQ:ARGX) on 3/3/2023
Structure Therapeutics stock logo
GPCR
Structure Therapeutics
$27.90
-6.9%
2/28/2023Reiterated byLeerink PartnersAnalyst D. RisingerOutperformLowView details for Leerink Partners rating of Structure Therapeutics (NASDAQ:GPCR) on 2/28/2023
Compugen stock logo
CGEN
Compugen
$1.53
+0.7%
2/28/2023Reiterated byLeerink PartnersAnalyst D. GrayboschOutperformLowView details for Leerink Partners rating of Compugen (NASDAQ:CGEN) on 2/28/2023
Disc Medicine stock logo
IRON
Disc Medicine
$64.50
+2.5%
2/28/2023Reiterated byLeerink PartnersAnalyst T. SmithOutperform$36.00LowView details for Leerink Partners rating of Disc Medicine (NASDAQ:IRON) on 2/28/2023
Xencor stock logo
XNCR
Xencor
$24.13
+0.5%
2/23/2023Reiterated byLeerink PartnersAnalyst J. ChangOutperformLowView details for Leerink Partners rating of Xencor (NASDAQ:XNCR) on 2/23/2023
Moderna stock logo
MRNA
Moderna
$39.39
-0.4%
2/24/2023Downgraded byLeerink PartnersAnalyst M. ForooharMarket Perform -> Underperform$111.00 -> $93.00LowView details for Leerink Partners rating of Moderna (NASDAQ:MRNA) on 2/24/2023
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$0.93
-1.3%
2/24/2023Target Lowered byLeerink Partners-Market Perform$5.00 -> $3.00N/AView details for Leerink Partners rating of Nektar Therapeutics (NASDAQ:NKTR) on 2/24/2023
Blueprint Medicines stock logo
BPMC
Blueprint Medicines
$90.14
+1.4%
2/24/2023Target Lowered byLeerink Partners-Market Perform$45.00 -> $38.00LowView details for Leerink Partners rating of Blueprint Medicines (NASDAQ:BPMC) on 2/24/2023
Ionis Pharmaceuticals stock logo
IONS
Ionis Pharmaceuticals
$35.63
+0.1%
2/23/2023Target Lowered byLeerink Partners-Market Perform$34.00 -> $27.00LowView details for Leerink Partners rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/23/2023
Teladoc Health stock logo
TDOC
Teladoc Health
$9.44
+5.2%
2/23/2023Upgraded byLeerink PartnersAnalyst S. DavisMarket Perform -> Outperform$34.00LowView details for Leerink Partners rating of Teladoc Health (NYSE:TDOC) on 2/23/2023
AbbVie stock logo
ABBV
AbbVie
$175.58
+2.4%
2/10/2023Upgraded byLeerink PartnersAnalyst D. RisingerUnderperform -> Market Perform$135.00 -> $153.00LowView details for Leerink Partners rating of AbbVie (NYSE:ABBV) on 2/10/2023
Enanta Pharmaceuticals stock logo
ENTA
Enanta Pharmaceuticals
$6.28
+7.2%
2/9/2023Reiterated byLeerink Partners-Market Perform$49.00LowView details for Leerink Partners rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 2/9/2023
Connect Biopharma stock logo
CNTB
Connect Biopharma
$0.95
-4.2%
2/8/2023Target Lowered byLeerink Partners-Outperform$9.00 -> $7.00LowView details for Leerink Partners rating of Connect Biopharma (NASDAQ:CNTB) on 2/8/2023
Equillium stock logo
EQ
Equillium
$0.61
+1.3%
2/8/2023Target Lowered byLeerink Partners-Outperform$12.00 -> $7.00LowView details for Leerink Partners rating of Equillium (NASDAQ:EQ) on 2/8/2023
The Cigna Group stock logo
CI
The Cigna Group
$276.92
+0.8%
2/8/2023Target Raised byLeerink Partners-Market Perform$309.00 -> $335.00LowView details for Leerink Partners rating of The Cigna Group (NYSE:CI) on 2/8/2023
Premier stock logo
PINC
Premier
$21.76
+1.2%
2/8/2023Target Lowered byLeerink Partners-Outperform$46.00 -> $42.00LowView details for Leerink Partners rating of Premier (NASDAQ:PINC) on 2/8/2023
Illumina stock logo
ILMN
Illumina
$136.02
+1.5%
2/8/2023Target Raised byLeerink PartnersAnalyst P. SoudaOutperform$249.00 -> $250.00LowView details for Leerink Partners rating of Illumina (NASDAQ:ILMN) on 2/8/2023
Vertex Pharmaceuticals stock logo
VRTX
Vertex Pharmaceuticals
$397.27
+0.2%
2/8/2023Target Lowered byLeerink Partners-Outperform$374.00 -> $365.00LowView details for Leerink Partners rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/8/2023
Incyte stock logo
INCY
Incyte
$68.84
+2.7%
2/8/2023Reiterated byLeerink Partners-Underperform$63.00LowView details for Leerink Partners rating of Incyte (NASDAQ:INCY) on 2/8/2023

MarketBeat Community Rating for Leerink Partners

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  33,882 (Vote Outperform)
Underperform Votes:  30,622 (Vote Underperform)
Total Votes:  64,504
MarketBeat's community ratings are surveys of what our community members think about Leerink Partners and other research firms. Vote "Outperform" if you believe Leerink Partners's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leerink Partners's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.